Friday, 16 October 2026European Markets

BELSHIPS And MAJOREL GROUP LUX Have A High Dividend Yield And Return On Equity In The Industrials Sector.

Loading stream...

(VIANEWS) - BELSHIPS (BELCO.OL) is among this list of stock assets with the highest dividend rate and return on equity on the Industrials sector.

Financial Asset Price Forward Dividend Yield Return on Equity
BELSHIPS (BELCO.OL) kr16.68 16.07% 50.41%
MAJOREL GROUP LUX (MAJ.AS) €29.10 2.33% 35.53%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. BELSHIPS (BELCO.OL)

16.07% Forward Dividend Yield and 50.41% Return On Equity

Belships ASA owns and operates dry bulk ships worldwide. It operates through Own Ships, Lighthouse Naviagtion, and Ship Management segments. The company operates a fleet of 34 Supra/Ultramax bulk carriers. It also provides commercial and ship management, technical, crewing, port agency, and logistical services. The company was founded in 1918 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, BELSHIPS has a trailing twelve months EPS of kr4.53.

PE Ratio

BELSHIPS has a trailing twelve months price to earnings ratio of 3.68. Meaning, the purchaser of the share is investing kr3.68 for every norwegian krone of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 50.41%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 50.8%, now sitting on 614.13M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BELSHIPS's stock is considered to be oversold (<=20).

More news about BELSHIPS.

2. MAJOREL GROUP LUX (MAJ.AS)

2.33% Forward Dividend Yield and 35.53% Return On Equity

Majorel Group Luxembourg S.A. engages in the designing, building, and delivering end-to-end customer experience (CX) solutions for digital-native and vertical leading brands worldwide. It offers customer interaction services, such as solutions for customer services, sales and marketing, loyalty and retention, and tech support; business process services, including content services, trust and safety, and vertical business process outsourcing services; and tech and expert services comprising digital consumer engagement, CX consulting, start-ups, and vertical digital solutions. The company serves Internet, banking and financial services, insurance, automotive, consumer products and retail, travel and hospitality, utilities and energy, and telecoms and media industries. Majorel Group Luxembourg S.A. was incorporated in 2018 and is headquartered in Luxembourg City, Luxembourg.

Earnings Per Share

As for profitability, MAJOREL GROUP LUX has a trailing twelve months EPS of €1.69.

PE Ratio

MAJOREL GROUP LUX has a trailing twelve months price to earnings ratio of 17.22. Meaning, the purchaser of the share is investing €17.22 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 35.53%.

Moving Average

MAJOREL GROUP LUX's worth is higher than its 50-day moving average of €28.75 and way above its 200-day moving average of €23.37.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jun 26, 2023, the estimated forward annual dividend rate is 0.68 and the estimated forward annual dividend yield is 2.33%.

Volume

Today's last reported volume for MAJOREL GROUP LUX is 23476 which is 70.27% below its average volume of 78970.

Yearly Top and Bottom Value

MAJOREL GROUP LUX's stock is valued at €29.10 at 07:30 EST, under its 52-week high of €29.80 and way higher than its 52-week low of €17.60.

More news about MAJOREL GROUP LUX.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com